TY - JOUR
T1 - Neural networks during delay discounting as trans-disease marker
T2 - A meta-analytical review
AU - Chen, Zhiyi
AU - Becker, Benjamin
AU - Qin, Pengmin
AU - Lei, Wei
AU - Chen, Jing
AU - Liu, Peiwei
AU - Lin, Tian
AU - Zhang, Chenyan
AU - Zhang, Rong
AU - Wang, Mengmeng
AU - Xu, Ting
AU - Yang, Yaqi
AU - Feng, Pan
AU - Feng, Tingyong
N1 - Funding Information:
This study was supported by the National Natural Science Foundation of China ( 31971026 , , Tingyong Feng; 31800959 , Pan Feng; 81701332 , Wei Lei) and the Fundamental Research Funds for the Central Universities ( SWU2009104 , Tingyong Feng; SWU1809357, Zhiyi Chen; SWU118091 , Pan Feng).
Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2021/7
Y1 - 2021/7
N2 - Delay discounting reflects a devaluation of delayed long-term benefits but pursuing immediate rewards. Higher discounting rates (h-DR) are found ubiquitous in many diseases and unhealthy conditions, particularly in addiction disorder (AD), attention-deficit/hyperactivity disorder (ADHD), and obesity. Thus, h-DR was considered to be a common benchmark across many diseases facilitating to understand one disease to relevant others, which was called trans-disease process. However, the common and specific neural biomarkers associated with this process has not yet been studied well. We performed a voxel-wise task-related neuroimaging meta-analysis to clarify the neural pattern of trans-disease process across AD, ADHD and obesity. We recruited 19 eligible papers, including 9 AD papers (154 patients), 6 ADHD papers (106 patients) and 4 obesity studies (94 patients). Neuroimaging meta-analysis demonstrated the presence of neural biomarkers of trans-disease process: these patients showed inadequate brain response in caudate, ventromedial and dorsolateral prefrontal cortex (dlPFC) than do of healthy controls (HCs). Disease-specific neural patterns were also found, with prominent hypoactivation in parahippocampal-striatum network for AD, hyperactivation in dopamine-projection striatum network for ADHD and decreased activity in dorsal anterior cingulate cortex and dlPFC for obesity. This study provided robust evidence to reveal the neural substrates of trans-disease process, as well further promoted the triple brain network model in favor of the theoretical developments of these neuropsychiatric disorders.
AB - Delay discounting reflects a devaluation of delayed long-term benefits but pursuing immediate rewards. Higher discounting rates (h-DR) are found ubiquitous in many diseases and unhealthy conditions, particularly in addiction disorder (AD), attention-deficit/hyperactivity disorder (ADHD), and obesity. Thus, h-DR was considered to be a common benchmark across many diseases facilitating to understand one disease to relevant others, which was called trans-disease process. However, the common and specific neural biomarkers associated with this process has not yet been studied well. We performed a voxel-wise task-related neuroimaging meta-analysis to clarify the neural pattern of trans-disease process across AD, ADHD and obesity. We recruited 19 eligible papers, including 9 AD papers (154 patients), 6 ADHD papers (106 patients) and 4 obesity studies (94 patients). Neuroimaging meta-analysis demonstrated the presence of neural biomarkers of trans-disease process: these patients showed inadequate brain response in caudate, ventromedial and dorsolateral prefrontal cortex (dlPFC) than do of healthy controls (HCs). Disease-specific neural patterns were also found, with prominent hypoactivation in parahippocampal-striatum network for AD, hyperactivation in dopamine-projection striatum network for ADHD and decreased activity in dorsal anterior cingulate cortex and dlPFC for obesity. This study provided robust evidence to reveal the neural substrates of trans-disease process, as well further promoted the triple brain network model in favor of the theoretical developments of these neuropsychiatric disorders.
KW - ADHD
KW - Meta-analysis
KW - NeuroImaging
KW - Trans-disease process
KW - Triple network system
UR - http://www.scopus.com/inward/record.url?scp=85106600964&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106600964&partnerID=8YFLogxK
U2 - 10.1016/j.jpsychires.2021.05.008
DO - 10.1016/j.jpsychires.2021.05.008
M3 - Article
C2 - 34044265
AN - SCOPUS:85106600964
SN - 0022-3956
VL - 139
SP - 62
EP - 70
JO - Journal of Psychiatric Research
JF - Journal of Psychiatric Research
ER -